Pictured: Marc Ladanyi & Laetitia Borsu
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, February 1, 2012

Memorial Sloan-Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

Pictured: Eric Pamer
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Friday, January 20, 2012

Infections are a common cause of complications in cancer patients. Now a Memorial Sloan-Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.

Pictured: Major Trends in Modern Cancer Research Seminar
Video
By Memorial Sloan-Kettering  |  Thursday, January 12, 2012

Hundreds of high school students and teachers attended our sixth annual Major Trends in Modern Cancer Research seminar to learn about cutting-edge biomedical research and to engage with leading scientists.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Feature
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, December 28, 2011

Years of innovative research, technology development, and facility expansion at Memorial Sloan-Kettering have led to several new experimental treatments for people with cancer.

Pictured: Craig Thompson
Perspective
By Craig Thompson, MD, President and CEO  |  Friday, December 23, 2011

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.

Pictured: Hans-Guido Wendel
Profile
By Jim Stallard, MA, Writer/Editor  |  Tuesday, December 20, 2011

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

Pictured: Nancy Lee
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, December 19, 2011

People with cancer of the nasopharynx, an area behind the nose, may benefit from a new combination therapy, according to an international study led by Memorial Sloan-Kettering radiation oncologist Nancy Y. Lee.

Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, December 15, 2011

Memorial Sloan-Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

Honor
By Media Staff  |  Wednesday, December 14, 2011

Five Memorial Sloan-Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.

Pictured: Structural formula of IBNtxA
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, December 13, 2011

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 12, 2011

A Memorial Sloan-Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.

Pictured: Lloyd J. Old
In Memoriam
By Memorial Sloan-Kettering  |  Sunday, December 4, 2011

Memorial Sloan-Kettering notes with sadness the death of Lloyd J. Old, who was internationally recognized as one of the founders and standard bearers of the field of tumor immunology.

Pictured: Breast tumor treated with paclitaxel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 2, 2011

Recent findings by Memorial Sloan-Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Pictured: David Solit
In the Lab
By Media Staff  |  Wednesday, November 23, 2011

Research led by investigators at Memorial Sloan-Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

Pictured: Evelyn Lauder
In Memoriam
By Memorial Sloan-Kettering  |  Monday, November 14, 2011

Memorial Sloan-Kettering mourns the loss of Evelyn H. Lauder, who was a tireless cancer research advocate and a member of our Board of Overseers.

Center News

Subscribe to Our E-newsletter

Get the latest information about cancer care.